Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect. 2011

Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
CNRS UMR7212, INSERM U944, Institut Universitaire d'Hématologie-Université Paris7 Diderot, 75475 Paris, France. alessia.zamborlini@univ-paris-diderot.fr

HIV-1 integrase (IN) orchestrates the integration of the reverse transcribed viral cDNA into the host cell genome and participates also in other steps of HIV-1 replication. Cellular and viral factors assist IN in performing its multiple functions, and post-translational modifications contribute to modulate its activities. Here, we show that HIV-1 IN is modified by SUMO proteins and that phylogenetically conserved SUMOylation consensus motifs represent major SUMO acceptor sites. Viruses harboring SUMOylation site IN mutants displayed a replication defect that was mapped during the early stages of infection, before integration but after reverse transcription. Because SUMOylation-defective IN mutants retained WT catalytic activity, we hypothesize that SUMOylation might regulate the affinity of IN for co-factors, contributing to efficient HIV-1 replication.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016662 Virus Integration Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA; (LYSOGENY); to form a PROPHAGE or integration of retroviral DNA into cellular DNA to form a PROVIRUS. Integration, Provirus,Integration, Virus,Provirus Integration,Viral integration,Integrations, Provirus,Integrations, Virus,Provirus Integrations,Viral integrations,Virus Integrations,integration, Viral,integrations, Viral
D048348 Reverse Transcription The biosynthesis of DNA carried out on a template of RNA. Transcription, Reverse
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell
D058207 Sumoylation A type of POST-TRANSLATIONAL PROTEIN MODIFICATION by SMALL UBIQUITIN-RELATED MODIFIER PROTEINS (also known as SUMO proteins). SUMO-Conjugation,SUMO Conjugation,SUMO-Conjugations,Sumoylations

Related Publications

Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
June 2022, Life science alliance,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
December 1994, Journal of virology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
August 1998, The Journal of general virology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
May 1995, Journal of virology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
August 1995, Virology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
November 2003, Journal of cell science,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
November 1995, Virology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
January 2001, Methods in enzymology,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
May 1993, Proceedings of the National Academy of Sciences of the United States of America,
Alessia Zamborlini, and Audrey Coiffic, and Guillaume Beauclair, and Olivier Delelis, and Joris Paris, and Yashuiro Koh, and Fabian Magne, and Marie-Lou Giron, and Joelle Tobaly-Tapiero, and Eric Deprez, and Stephane Emiliani, and Alan Engelman, and Hugues de Thé, and Ali Saïb
April 1995, Biochemical pharmacology,
Copied contents to your clipboard!